Differentiation Therapy of Acute Promyelocytic Leukemia: Clinical and Molecular Features

References

• Hong W. K., Itri L. M. Retinoids and human cancer. The Retinoids: Biology, Chemistry, and Medicine, M. B. Sporn, A. B. Roberts, D. S. Goodman. Raven Press, New York 1994; 597–630
   Google Scholar
• McCollum E. V., Davis M. The necessity of certain lipins in the diet during growth. J Biol Chem 1913; 15: 167–175
   Google Scholar
• Sporn M. B., Roberts A. B., Goodman D. S. The Retinoids. Academic Press, Orlando, FL 1984
   Google Scholar
• Sporn M. B., Roberts A. B., Goodman D. S. The Retinoids: Biology, Chemistry, and Medicine, 2nd ed. Raven Press, New York 1994
   Google Scholar
• Mangelsdorf D. J., Umesono K., Evans R. M. The retinoid receptors. The Retinoids: Biology, Chemistry, and Medicine, M. B. Sporn, A. B. Roberts, D. S. Goodman. Raven Press, New York 1994; 319–349
   Google Scholar
• Collins S. J., Robertson K. A., Mueller L. Retinoic acid-induced gran-ulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RAR-α). Mol Cell Biol 1990; 10: 2154–2163
   PubMed Web of Science ®Google Scholar
• Breitman T. R., Selonick S. E., Collins S. J. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 1980; 77: 2936–2940
   PubMed Web of Science ®Google Scholar
• Huang M. E., Ye Y. C., Chen S. R., Chai J. R., Lu J. X., Zhoa L., Gu U., Wang Z.-Y. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988; 72: 567–572
   PubMed Web of Science ®Google Scholar
• Castaigne S., Chomienne C., Daniel M. T., Berger R., Fenaux P., Degos L. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 1990; 76: 1704–1709
   PubMed Web of Science ®Google Scholar
• Warrell R. P., Jr, Frankel S. R., Mill W. H., Jr, Scheinberg D. A., Itri L. M., Hittelman W. N., Vyas R., Andreeff M., Tafuri A., Jakubowski A., Gabrilove J., Gordon M. S., Dmitrovsky E. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 1991; 324: 1385–1393
   PubMed Web of Science ®Google Scholar
• Chen Z. X., Xue Y. Q., Zhang R., Tao R. F., Xia X. M., Li C., Wang W., Zu W. Y., Yao X. Z., Ling B. J. A clinical and experimental study on all-trans retinoic acid treated acute promyelocytic leukemia patients. Blood 1991; 78: 1413–1419
   PubMed Web of Science ®Google Scholar
• Warrell R. P., Jr, de The H., Wang Z.-Y., Degos L. Acute promyelocytic leukemia. N Engl J Med 1993; 329: 177–189
   PubMed Web of Science ®Google Scholar
• Frankel S. R., Eardley A., Heller G., Berman E., Miller W. H., Jr, Dmitrovsky E., Warrell R. P., Jr. All-trans retinoic acid for acute promyelocytic leukemia, Results of the New York study. Ann Intern Med 1994; 120: 278–286
   PubMed Web of Science ®Google Scholar
• Eardley A. M., Heller G., Warrell R. P., Jr. Morbidity and costs of remission induction therapy with all-trans retinoic acid compared with standard chemotherapy in acute promyelocytic leukemia. Leukemia 1994, (in press)
   Web of Science ®Google Scholar
• Tallman M. S., Hakimian D., Kwaan H. C., Rickles F. R. New insights into the pathogenesis of coagulation dysfunction in acute promyelocytic leukemia. Leuk Lymphoma 1993; 11: 27–36
   PubMed Web of Science ®Google Scholar
• Fenaux P., Le Deley M. C., Castaigne S., Archimbaud E., Chomienne C., Link H., Guerci A., Duarte M., Daniel M. T., Bowen D., Huebner G., et al. Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia: Results of a multicenter randomized trial. Blood 1993; 82: 3241–3249
   PubMed Web of Science ®Google Scholar
• Degos L., Dombret H., Chomienne C., Daniel M. T., Micléa J. M., Chastang C., Castaigne S., Fenaux P. All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. Blood 1995; 85: 2643–2653
   PubMed Web of Science ®Google Scholar
• Frankel S. R., Eardley A., Lauwers G., Weiss M., Warrell R. P., Jr. The “retinoic acid syndrome” in acute promyelocytic leukemia. Ann Intern Med 1992; 117: 292–296
   PubMed Web of Science ®Google Scholar
• Seiter K., Feldman E., Miller W. H., Jr, DeBlasio A., Levine K., Ahmed T., Arlin Z. All trans retinoic acid (ATRA) following induction chemotherapy for acute promyelocytic leukemia. Blood 1993; 82(Suppl 1)250a, (abstract)
   Google Scholar
• de The H., Chomienne C., Lanotte M., Degos L., Dejean A. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus. Nature 1990; 347: 558–561
   PubMed Web of Science ®Google Scholar
• Miller W. H., Jr, Warrell R. P., Jr, Frankel S. R., Jakubowski A., Gabrilove J. L., Muindi J., Dmitrovsky E. Novel retinoic acid receptor-α transcripts in acute promyelocytic leukemia responsive to all-trans-retinoic acid. J Natl Cancer Inst 1990; 32: 1932–1933
   Google Scholar
• Chomienne C., Ballerini P., Balitrand N., Huang M. E., Krawice I., Castaigne S., Fenaux P., Tiollais P., Dejean A., Degos L., de The H. The retinoic acid receptor alpha gene is rearranged in retinoic acid-sensitive promyelocytic leukemias. Leukemia 1990; 4: 802–807
   PubMed Web of Science ®Google Scholar
• Alcalay M., Zangrilli D., Pandolfi P. P., Longo L., Mencarelli A., Giacomucci A., Rocchi M., Biondi A., Rambaldi A., Lo Coco F., Diverio D., Donti E., Grignani F., Pelicci P. G. Translocation breakpoint of acute promyelocytic leukemia lies within the retinoic acid receptor alpha locus. Proc Natl Acad Sci USA 1991; 88: 1977–1981
   PubMed Web of Science ®Google Scholar
• Kakizuka A., Miller W. H., Jr, Umesono K., Warrell R. P., Jr, Frankel S. R., Murty V. VVS, Dmitrovsky E., Evans R. M. Chromosomal translocation t(15;17) in human acute promyelocylic leukemia fuses RARα with a novel putative transcription factor, PML. Cell 1991; 66: 663–674
   PubMed Web of Science ®Google Scholar
• de The H., Lavau C., Marcio A., Chomienne C., Degos L., Dejean A. The PML-RAR-α fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 1991; 66: 675–684
   PubMed Web of Science ®Google Scholar
• Grignani F., Fagioli M., Alcalay M., Longo L., Pandolfi P. P., Donti E., Biondi A., Lo Coco F., Pelicci P. G. Acute promyelocytic leukemia: From genetics to treatment. Blood 1994; 83: 10–25
   PubMed Web of Science ®Google Scholar
• Kastner P., Perez A., Lutz Y., Rochette-Egly C., Gaub M. P., Durand B., Lanotte M., Berger R., Chambon P. Structure, localization and transcriptional properties of two classes of retinoic acid receptor α fusion proteins in acute promyelocytic leukemia (APL): Structural similarities with a new family of oncoproteins. EMBO J 1992; 11: 629–642
   PubMed Web of Science ®Google Scholar
• Dyck J. A., Maul G. G., Miller W. H., Jr, Chen J. D., Kakizuka A., Evans R. M. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 1994; 76: 1–20
   PubMedGoogle Scholar
• Daniel M. T., Koken M., Romagne O., Barbely S., Bazarbachi A., Stadler M., Guillemin M. C., Degos L., Chomienne C., de The H. PML protein expression in hematopoietic and acute promyelocytic leukemia cells. Blood 1993; 82: 1858–1866
   PubMed Web of Science ®Google Scholar
• Weis K., Rambaud S., Lavau C., Jansen J., Carvalho T., Carmo-Fonseca M., Lamond A., Dejean A. Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cells. Cell 1994; 76: 345–356
   PubMed Web of Science ®Google Scholar
• Dyck J. A., Warrell R. P., Jr, Evans R. M., Miller W. H., Jr. Rapid diagnosis of acute promyelocytic leukemia by immunohistochemical localization of PML/RAR-α protein. Blood 1995; 86: 862–867
   PubMed Web of Science ®Google Scholar
• Muindi J., Frankel S. R., Huselton C., DeGrazia F., Garland W. A., Young C. W., Warrell R. P., Jr. Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. Cancer Res 1992; 52: 2138–2142
   PubMed Web of Science ®Google Scholar
• Muindi J., Frankel S. R., Miller W. H., Jr, Jakubowski A., Scheinberg D. A., Young C. W., Dmitrovsky E., Warrell R. P., Jr. Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: Implications for relapse and retinoid “resistance” in patients with acute promyelocytic leukemia. Blood 1992; 79: 299–303
   PubMed Web of Science ®Google Scholar
• Delva L., Comic M., Balitrand N., Guidez F., Micléa J.-M., Delmer A., Teillet F., Fenaux P., Castaigne S., Degos L., Chomienne C. Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: Study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells. Blood 1993; 82: 2175–2181
   PubMed Web of Science ®Google Scholar
• Warrell R. P., Jr. Retinoid resistance in acute promyelocytic leukemia: New mechanisms, strategies, and implications. Blood 1993; 82: 1949–1953
   PubMed Web of Science ®Google Scholar
• Levin A. A., Sturzenbecker L. J., Kazmer S., Bosakowski T., Huselton C., Allenby G., Speck J., Kratzeisen C., Rosenberger M., Lovey A., Grippo J. F. 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα. Nature 1992; 355: 359–361
   PubMed Web of Science ®Google Scholar
• Heyman R. A., Mangelsdorf D. J., Dyck J. A., Stein R. B., Eichele G., Evans R. M., Thaller C. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 1992; 68: 397–406
   PubMed Web of Science ®Google Scholar
• Achkar C. C., Bentel J. M., Boylan J. F., Scher H. I., Gudas L. J., Miller W. H., Jr. Differences in the pharmacokinetic properties of orally administered all-trans-retinoic acid and 9-cis-retinoic acid in the plasma of nude mice. Drug Metab Dispos 1994; 22: 451–458
   PubMed Web of Science ®Google Scholar
• Adamson P. C., Murphy R. F., Godwin K. A., Ulm E. H., Balis F. M. Pharmacokinetics of 9-cis retinoic acid in the rhesus monkey. Cancer Res 1995; 55: 482–485
   PubMed Web of Science ®Google Scholar
• Miller W. H., Jr, Jakubowski A., Tong W. P., Miller V. A., Rigas J. R., Benedetti F., Gill G. M., Truglia J. A., Ulm E., Shirley M., Warrell R. P., Jr. 9-cis retinoic acid induces complete remission but does not reverse clinically acquired retinoid resistance in acute promyelocytic leukemia. Blood 1995; 85: 3021–3027
   PubMed Web of Science ®Google Scholar
• Lanotte M., Martin-Thouvenin V., Najman S., Ballerini P., Valensi F., Bergen R. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 1991; 77: 1080–1086
   PubMed Web of Science ®Google Scholar
• Duprez E., Ruchaud S., Houge G., Martin-Thouvenin V., Valensi F., Kastner Ph, Berger R., Lanotte M. A retinoid acid “resistant” t(15;17) acute promyelocytic leukemia cell line: Isolation, morphological, immunological and molecular features. Leukemia 1992; 6: 1281–1287
   PubMed Web of Science ®Google Scholar
• Dermine S., Grignani F., Clerici M., Nervi C., Sozzi G., Talamo G. P., Marcheis E., Formelli F., Parmiani G., Pelicci P. G., Gambacorti-Passerini C. Occurrence of resistance to retinoic acid in the acute promyelocytic leukemia cell line NB4 is associated with altered expression of the pml/RARα protein. Blood 1993; 82: 1573–1577
   PubMed Web of Science ®Google Scholar
• Miller W. H., Jr, Kakizuka A., Frankel S. R., Warrell R. P., Jr, DeBlasio A., Levine K., Evans R. M., Dmitrovsky E. Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor-α clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia. Proc Natl Acad Sci USA 1992; 89: 2694–2698
   PubMed Web of Science ®Google Scholar
• Levine K., DeBlasio A., Miller W. H., Jr. Molecular diagnosis and monitoring of acute promyelocytic leukemia treated with retinoic acid. Leukemia 1994; 8: S116–S120
   PubMed Web of Science ®Google Scholar
• Castaigne S., Balitrand N., de The H., Dejean A., Degos L., Chomienne C. A PML/retinoic acid receptor α fusion transcript is constantly detected by RNA-based polymerase chain reaction in acute promyelocytic leukemia. Blood 1992; 79: 3110–3115
   PubMed Web of Science ®Google Scholar
• Chang K.-S., Lu J., Wang G., Trujillo J. M., Estey E., Cork A., Chu D.-T., Freireich E. J., Stass S. A. The t(15;17) breakpoint in acute promyelocytic leukemia cluster within two different sites of the myl gene: Targets for the detection of minimal residual disease by the polymerase chain reaction. Blood 1992; 79: 554–558
   PubMed Web of Science ®Google Scholar
• Lo Coco F., Diverio D., Pandolfi P. P., Biondi A., Rossi V., Avvisati G., Rambaldi A., Arcese W., Petti M. C., Meloni G., Mandelli F., Grignani F., Masera G., Barbui T., Pelicci P. G. Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukemia. Lancet 1992; 340: 1437–1438
   PubMed Web of Science ®Google Scholar
• Miller W. H., Jr, Levine K., DeBlasio A., Frankel S. R., Dmitrovsky E., Warrell R. P., Jr. Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reacton assay for the PML/RAR-α fusion mRNA. Blood 1993; 82: 1689–1694
   PubMed Web of Science ®Google Scholar
• Nucifora G., Larson R. A., Rowley J. D. Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission. Blood 1993; 82: 712–715
   PubMed Web of Science ®Google Scholar
• Moon R. C., Mehta R. G., Rao K. VN. Retinoids and cancer in experimental animals. The Retinoids: Biology, Chemistry, and Medicine, M. B. Spom, A. B. Roberts, D. S. Goodman. Raven Press, New York 1994; 573–595
   Google Scholar
• Connett J. E., Kuller L. H., Kjelsberg M. O., Polk B. F., Collins G., Rider A., Hulley S. B. Relationship between carotenoids and cancer: The Multiple Risk Factor Intervention Trial (MRFIT) study. Cancer 1989; 64: 1266–134
   PubMedGoogle Scholar
• Knekt P., Jarvinen R., Seppanen R., Rissanen A., Aromaa A., Heinonen O. P., Albanes D., Heinonen M., Pukkala E., Teppo L. Dietary antioxidants and the risk of lung cancer. Am J Epidemiol 1991; 1314: 471–479
   Google Scholar
• Hong W. K., Endicott J., Itri L. M., Doos W., Bastsakis J. G., Bell R., Fofonoff S., Byers R., Atkinson E. N., Vaughan C. 13-cis retinoic acid in the treatment of oral leukoplakia. N Engl J Med 1986; 315: 1501–1505
   PubMed Web of Science ®Google Scholar
• Kraemer K. H., DiGiovanna J. J., Moshell A. N., Tarone R. E., Peck G. L. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N Engl J Med 1988; 318: 1633–1637
   PubMed Web of Science ®Google Scholar
• Meyskens F. L., Jr, Surwit E., Moon T. E., Davis J., Alberts D. S. A placebo-controlled, randomized phase III trial of locally applied β-trans retinoic acid (vitamin A acid, RA) in cervical intraepithelial neoplasia (CIN): Favorable effect on CIN II (moderate dysplasia). Proc Am Soc Clin Oncol 1993; 12: 167, (abstract)
   Google Scholar
• Hong W. K., Lippman S. M., Itri L. M., Karp D. D., Lee J. S., Byers R. M., Schantz S. P., Kramer A. M., Lotan R., Peters L. J. Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck. N Engl J Med 1990; 323: 795–801
   PubMed Web of Science ®Google Scholar
• Licht J. D., Chomienne C., Goy A., Chen A., Scott A. A., Head D. R., Michaux J. L., Wu Y., DeBlasio A., Miller W. H., Jr, Zelentz A. D., Willman C. L., Chen Z., Chen S. J., Zelent A., Macintyre E., Veil A., Cortes J., Kantarjian H., Waxman S. Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation(11;17). Blood 1995; 85: 1083–1094
   PubMed Web of Science ®Google Scholar
• Brown G., Bunce C. M., Rowlands D. C., Williams G. R. All-trans retinoic acid and 1α,25-dihydroxy vitamin D3 co-operate to promote differentiation of human promy eloid leukemia cell line HL60 to monocytes. Leukemia 1994; 8: 806–815
   PubMed Web of Science ®Google Scholar
• Bunce C. M., French P. J., Durham J., Stockley R. A., Michell R. H., Brown G. Indomethacin potentiates the induction of HL60 differentiation to neutrophils, by retinoic acid and granulocyte colony-stimulating factor, and to monocytes, by vitamin D3. Leukemia 1994; 8: 595–604
   PubMed Web of Science ®Google Scholar
• Gianni M., Terao M., Zanotta S., Barbui T., Rambaldi A., Garattini E. Retinoic acid and granulocyte colony-stimulating factor synergistically induce leukocyte alkaline phosphatase in acute promyelocytic leukemia cells. Blood 1994; 83: 1909–1921
   PubMed Web of Science ®Google Scholar
• Kizaki M., Nakajima H., Mori S., Koike T., Morikawa M., Ohta M., Saito M., Koeffler H. P., Ikeda Y. Novel retinoic acid, 9-cis retinoic acid, in combination with all-trans retinoic acid is an effective inducer of differentiation of retinoic acid-resistant HL-60 cells. Blood 1994; 11: 3289–3297
   Google Scholar
• Lippman S. M., Parkinson D. R., Itri L. M., Weber R. S., Schantz S. P., Ota D. M., Schusterman M. A., Krakoff I. H., Gutterman J. U., Hong W. K. 13-cis-retinoic acid and interferon-alpha-2a: Effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst 1993; 84: 235–240
   Web of Science ®Google Scholar
• Lippman S. M., Kavanagh J. J., Paredes-Espinoza M., Delgadillo-Madrueno F., Paredes-Casillas P., Hong W. K., Holdener E., Krakoff I. H. 13-cis-retinoic acid plus interferon-alpha-2a: Highly active systemic therapy for squamous cell carcinoma of the cervix. J Natl Cancer Inst 1993; 84: 241–245
   Web of Science ®Google Scholar
• Law T. M., Murphy B. A., Hoffman A. D., Albino A. P., Vlamis V., Nanus D. M. Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: Antitumor activity in a phase II trial and interactions in vitro. J Clin Oncol 1995; 13: 1950–1957
   PubMed Web of Science ®Google Scholar